- cafead Mar 23, 2023 at 09:23: PM
via Can a promising new way of treating common immune diseases like psoriasis also work for disorders of the brain and nervous system?
Biohaven, a biotechnology company rebooted after a 2022 sale to Pfizer, aims to find out, announcing Wednesday a deal to license a so-called TYK2 inhibitor from Chinese drugmaker Hangzhou Highlightll Pharmaceutical.
article source
Biohaven, a biotechnology company rebooted after a 2022 sale to Pfizer, aims to find out, announcing Wednesday a deal to license a so-called TYK2 inhibitor from Chinese drugmaker Hangzhou Highlightll Pharmaceutical.
article source